Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis

Nephrology

Volumn 17, Issue 4, 2012, Pages 346-351

  Lu, Jianxin ^a   Kwan, Bonnie Ching Ha ^a   Lai, Fernand Mac Moune ^a   Tam, Lai Shan ^a   Li, Edmund Kwok Ming ^a   Chow, Kai Ming ^a   Wang, Gang ^a   Li, Philip Kam Tao ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

gene regulation; lupus nephritis; proteinuria

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 198; MICRORNA 638; MICRORNA 663; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLOMERULUS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY TUBULE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEINURIA;

ADULT; BIOPSY; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; GLOMERULAR FILTRATION RATE; HONG KONG; HUMANS; KIDNEY GLOMERULUS; KIDNEY TUBULES; LUPUS NEPHRITIS; MALE; MICRORNAS; MIDDLE AGED; PROTEINURIA; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 84860191079     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2012.01573.x     Document Type: Article

References (26)

1. Cook HT, Botto M,. Mechanisms of disease: The complement system and the pathogenesis of systemic lupus erythematosus. Nat. Clin. Pract. Rheumatol. 2006; 2: 330-37. (Pubitemid 43842262)
2. Rahman A, Isenberg DA,. Systemic lupus erythematosus. N. Engl. J. Med. 2008; 358: 929-39. (Pubitemid 351397092)
3. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y,. Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Semin. Arthritis Rheum. 2004; 34: 501-37. (Pubitemid 40288129)
4. Mok CC, Lau CS,. Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 2003; 56: 481-90. (Pubitemid 36819418)
5. Zhang B, Farwell MA,. microRNAs: A new emerging class of players for disease diagnostics and gene therapy. J. Cell. Mol. Med. 2008; 12: 3-21.
6. Pauley KM, Cha S, Chan EK,. MicroRNA in autoimmunity and autoimmune diseases. J. Autoimmun. 2009; 32: 189-94.
7. Lu LF, Liston A,. MicroRNA in the immune system, microRNA as an immune system. Immunology 2009; 127: 291-8.
8. Liang TJ, Qin CY,. The emerging role of microRNAs in immune cell development and differentiation. APMIS 2009; 117: 635-43.
9. Te JL, Dozmorov IM, Guthridge JM, et al,. Identification of unique microRNA signature associated with lupus nephritis. PLoS ONE 2010; 5: e10344.
10. Wang G, Kwan BC, Lai FM, Chow KM, Li PK, Szeto CC,. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis. Markers 2011; 30: 171-9.
11. Wang G, Tam LS, Li EK, et al,. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 2011; 20: 493-500.
12. Wang G, Tam LS, Li EK, et al,. Serum and urinary cell free miR-146a and miR-155 in patients with systemic lupus erythematosus. J. Rheumatol. 2010; 37: 2516-22.
13. Dai Y, Huang YS, Tang M, et al,. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007; 16: 939-46.
14. Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y,. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol. Int. 2009; 29: 749-54.
15. Hochberg M,. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40: 1725-35.
16. Lu JX, Kwan BC, Lai FM, et al,. The gene expression of TWEAK/Fn14 and IP-10/CXCR3 in glomerulus and tubulo-interstitium of patients with lupus nephritis. Nephrology (Carlton) 2011; 16: 426-32.
17. Bombardier C, Gladman D, Urowitz M, Caron D, Chang C,. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992; 35: 630-40.
18. Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. modification of diet in renal disease study group. Ann. Intern. Med. 1999; 130: 461-70. (Pubitemid 29135798)
19. Weening J, D'Agati V, Schwartz M, et al,. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004; 65: 521-30. (Pubitemid 38130646)
20. Wang G, Lai FM, Lai KB, et al,. Discrepancy between intra-renal messenger RNA and protein expression of ACE and ACE2 in human diabetic nephropathy. Am. J. Nephrol. 2008; 29: 524-31.
21. Lu JX, Szeto CC,. Gene expression using the PALM system. Methods Mol. Biol. 2011; 755: 47-56.
22. Panguluri SK, Bhatnagar S, Kumar A, et al,. Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of tweak-induced skeletal muscle wasting in mice. PLoS ONE 2010; 5: e8760.
23. Taganov KD, Boldin MP, Chang KJ, Baltimore D,. NF-κb-dependent induction of microrna MIR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 12481-6. (Pubitemid 44267285)
24. Tang Y, Luo X, Cui H, et al,. MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009; 60: 1065-75.
25. Luo X, Yang W, Ye DQ, et al,. A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet. 2011; 7: e1002128.
26. Stagakis E, Bertsias G, Verginis P, et al,. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann. Rheum. Dis. 2011; 70: 1496-506.